Core Viewpoint - RF Industries, Ltd. reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, and showing a significant improvement from a loss of $0.01 per share a year ago [1] Financial Performance - The company achieved revenues of $19.79 million for the quarter ended July 2025, surpassing the Zacks Consensus Estimate by 6.86%, compared to $16.84 million in the same quarter last year [2] - Over the last four quarters, RF Industries has exceeded consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - RF Industries shares have increased approximately 96.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 11.1% [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.08 on revenues of $19.75 million, and for the current fiscal year, it is $0.24 on revenues of $76.37 million [7] - The estimate revisions trend for RF Industries was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Semiconductors - Radio Frequency industry, to which RF Industries belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]

Core Insights - Vera Bradley reported a quarterly loss of $0.02 per share, outperforming the Zacks Consensus Estimate of a loss of $0.15, marking an earnings surprise of +86.67% [1] - The company generated revenues of $70.86 million for the quarter ended July 2025, missing the Zacks Consensus Estimate by 9.76% and down from $110.82 million year-over-year [2] - The stock has underperformed, losing about 42% since the beginning of the year compared to the S&P 500's gain of 11.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $63.95 million, and for the current fiscal year, it is -$0.63 on revenues of $275.2 million [7] - The estimate revisions trend for Vera Bradley was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Retail - Apparel and Shoes industry, to which Vera Bradley belongs, is currently in the bottom 40% of the Zacks Industry Rank, which may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]

Core Insights - Core Molding Technologies, Inc. (CMT) shares increased by 8.2% to $20.98 in the last trading session, with a notable trading volume, and a total gain of 13.1% over the past four weeks [1][2] Company Performance - The recent stock rally is attributed to optimism regarding increased customer demand for molded thermoplastic and thermoset products in industrial and utilities markets, alongside new program wins in construction, aerospace, energy, and medical sectors [2] - Core Molding is projected to report quarterly earnings of $0.40 per share, reflecting an 11.1% year-over-year increase, while revenues are expected to be $70.36 million, a decrease of 3.6% from the previous year [3] - The consensus EPS estimate for Core Molding has remained stable over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Core Molding Technologies operates within the Zacks Rubber - Plastics industry, where another company, Myers (MYE), experienced a 0.5% decline in its stock price, with a return of -2.2% over the past month [4] - Myers' consensus EPS estimate has also remained unchanged at $0.24, representing a 4% decrease compared to the previous year [5]

Core Viewpoint - Lovesac reported a quarterly loss of $0.45 per share, which was better than the Zacks Consensus Estimate of a loss of $0.72, indicating a positive earnings surprise of +37.50% [1] - The company has shown mixed performance in revenue, with $160.53 million reported for the quarter, slightly missing the consensus estimate by 0.2% [2] Financial Performance - The loss per share of $0.45 compares to a loss of $0.38 per share a year ago, indicating a deterioration in year-over-year performance [1] - Over the last four quarters, Lovesac has surpassed consensus EPS estimates four times and topped revenue estimates two times [2] Stock Performance - Lovesac shares have declined approximately 12.3% since the beginning of the year, contrasting with the S&P 500's gain of 11.1% [3] - The current Zacks Rank for Lovesac is 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is -$0.27 on revenues of $154.51 million, while for the current fiscal year, it is $0.90 on revenues of $706.8 million [7] - The trend of earnings estimate revisions is mixed ahead of the earnings release, which could influence future stock performance [6] Industry Context - The Retail - Home Furnishings industry, to which Lovesac belongs, is currently ranked in the bottom 15% of over 250 Zacks industries, which may negatively impact stock performance [8]

Core Insights - KalVista Pharmaceuticals, Inc. reported a quarterly loss of $1.12 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.91, marking an earnings surprise of -23.08% [1] - The company generated revenues of $1.43 million for the quarter ended July 2025, missing the Zacks Consensus Estimate by 20.91%, compared to zero revenues a year ago [2] - The stock has increased approximately 81.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 11.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.89 on revenues of $5.46 million, and for the current fiscal year, it is -$3.06 on revenues of $30.02 million [7] - The estimate revisions trend for KalVista Pharmaceuticals was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Drugs industry, to which KalVista Pharmaceuticals belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]

Group 1 - eGain reported quarterly earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.07 per share, and showing an increase from $0.08 per share a year ago, resulting in an earnings surprise of +28.57% [1] - The company achieved revenues of $23.23 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.55% and increasing from $22.46 million year-over-year [2] - eGain has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - eGain shares have increased by approximately 0.2% since the beginning of the year, while the S&P 500 has gained 9.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $23.73 million, and for the current fiscal year, it is $0.23 on revenues of $97.93 million [7] Group 3 - The Zacks Industry Rank indicates that the Internet - Software sector is in the top 29% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this category [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for eGain was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Core Viewpoint - DocuSign reported quarterly earnings of $0.92 per share, exceeding the Zacks Consensus Estimate of $0.84 per share, but down from $0.97 per share a year ago, indicating an earnings surprise of +9.52% [1][2] Financial Performance - The company achieved revenues of $800.64 million for the quarter ended July 2025, surpassing the Zacks Consensus Estimate by 2.78% and up from $736.03 million year-over-year [2] - Over the last four quarters, DocuSign has consistently exceeded consensus EPS estimates and revenue expectations [2] Stock Performance - DocuSign shares have declined approximately 15.6% since the beginning of the year, contrasting with the S&P 500's gain of 9.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.89 on revenues of $795.56 million, and for the current fiscal year, it is $3.54 on revenues of $3.16 billion [7] - The outlook for the Internet - Software industry, where DocuSign operates, is favorable, ranking in the top 29% of over 250 Zacks industries, suggesting potential for outperformance [8]

Core Viewpoint - Zumiez reported a quarterly loss of $0.06 per share, which was better than the Zacks Consensus Estimate of a loss of $0.11, indicating a positive earnings surprise of +45.45% [1] - The company has shown mixed performance in terms of earnings estimates, with a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the market in the near future [6] Financial Performance - Zumiez posted revenues of $214.28 million for the quarter ended July 2025, surpassing the Zacks Consensus Estimate by 1.78% and showing an increase from $210.18 million year-over-year [2] - The company has exceeded consensus revenue estimates three times over the last four quarters [2] Stock Performance - Zumiez shares have declined approximately 8.5% since the beginning of the year, contrasting with the S&P 500's gain of 9.6% [3] - The sustainability of the stock's price movement will depend on management's commentary during the earnings call [3] Future Outlook - Current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $223.07 million, and for the current fiscal year, it is $0.16 on revenues of $901.34 million [7] - The outlook for the Retail - Apparel and Shoes industry, where Zumiez operates, is currently in the bottom 39% of Zacks industries, which may impact the stock's performance [8]

Core Viewpoint - Endava PLC reported quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32 per share, but showing an increase from $0.28 per share a year ago, indicating a -3.12% earnings surprise [1][2] Financial Performance - The company posted revenues of $239.41 million for the quarter ended June 2025, which was 4.22% below the Zacks Consensus Estimate and a decrease from $245.3 million year-over-year [2] - Over the last four quarters, Endava has surpassed consensus EPS estimates three times, but has only topped consensus revenue estimates once [2] Stock Performance - Endava shares have declined approximately 53.5% since the beginning of the year, contrasting with the S&P 500's gain of 9.6% [3] - The current Zacks Rank for Endava is 4 (Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.38 on revenues of $252.72 million, and for the current fiscal year, it is $1.56 on revenues of $1.02 billion [7] - The outlook for the Computers - IT Services industry, where Endava operates, is currently in the bottom 39% of Zacks industries, which may negatively impact stock performance [8]

Group 1 - Ciena reported quarterly earnings of $0.67 per share, exceeding the Zacks Consensus Estimate of $0.52 per share, and showing an increase from $0.35 per share a year ago, resulting in an earnings surprise of +28.85% [1] - The company achieved revenues of $1.22 billion for the quarter ended July 2025, surpassing the Zacks Consensus Estimate by 4.00%, compared to $942.31 million in the same quarter last year [2] - Ciena's stock has increased approximately 11.8% since the beginning of the year, outperforming the S&P 500's gain of 9.6% [3] Group 2 - The future performance of Ciena's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][5] - The current consensus EPS estimate for the upcoming quarter is $0.66 on revenues of $1.21 billion, and for the current fiscal year, it is $2.26 on revenues of $4.58 billion [7] - The Communication - Components industry, to which Ciena belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, indicating potential challenges ahead [8]